RN7SL163P

Across TCGA pan-cancer cohorts, RN7SL163P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RN7SL163P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RN7SL163P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL163P expression acts as an unfavorable survival marker, although some lineages such as STAD and UCS show a favorable association.

STAD, CHOL, and THYM are the cancer types where RN7SL163P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Quartile	All	0.580	0.329	<.001	84	view →
CHOL	OS	Tertile	III,IV	0.162	0.915	.004	40	view →
THYM	OS	Tertile	All	0.782	0.982	.013	24	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
UCS	OS	Tertile	IV	1.000	0.293	.035	18	view →
UCEC	DFS	Tertile	II,III,IV	0.956	0.805	.035	18	view →
ESCA	OS	Quartile	II,III,IV	0.531	0.757	.013	13	view →
LAML	DFS	Tertile	All	0.663	0.366	.016	12	view →
KICH	DFS	Tertile	II,III,IV	0.102	0.775	.025	9	view →
THCA	DFS	Tertile	All	0.971	0.806	.009	9	view →
MESO	DFS	Tertile	III,IV	0.137	0.523	.011	9	view →
COAD	DFS	Tertile	IV	0.099	0.515	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RN7SL163P–STAD (OS)

Open the STAD breakdown →